Cite
HARVARD Citation
Wyles, D. et al. (2017). Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure. Hepatology. 66 (6), pp. 1794-1804. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Wyles, D. et al. (2017). Grazoprevir, ruzasvir, and uprifosbuvir for hepatitis C virus after NS5A treatment failure. Hepatology. 66 (6), pp. 1794-1804. [Online].